- Home
- CBUS vs NEUE Comparison
CBUS vs NEUE Comparison
Compare CBUS & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- NEUE
- Stock Information
- Founded
- CBUS 2010
- NEUE 2015
- Country
- CBUS United States
- NEUE United States
- Employees
- CBUS N/A
- NEUE N/A
- Industry
- CBUS Agricultural Chemicals
- NEUE
- Sector
- CBUS Industrials
- NEUE
- Exchange
- CBUS Nasdaq
- NEUE NYSE
- Market Cap
- CBUS 65.3M
- NEUE 61.3M
- IPO Year
- CBUS 2017
- NEUE 2021
- Fundamental
- Price
- CBUS $1.50
- NEUE $6.81
- Analyst Decision
- CBUS Strong Buy
- NEUE Hold
- Analyst Count
- CBUS 3
- NEUE 1
- Target Price
- CBUS $22.00
- NEUE $7.00
- AVG Volume (30 Days)
- CBUS 709.5K
- NEUE 5.3K
- Earning Date
- CBUS 08-07-2025
- NEUE 08-06-2025
- Dividend Yield
- CBUS N/A
- NEUE N/A
- EPS Growth
- CBUS N/A
- NEUE N/A
- EPS
- CBUS N/A
- NEUE N/A
- Revenue
- CBUS $4,751,000.00
- NEUE $907,349,000.00
- Revenue This Year
- CBUS $32.97
- NEUE $33.99
- Revenue Next Year
- CBUS $66.40
- NEUE $5.90
- P/E Ratio
- CBUS N/A
- NEUE N/A
- Revenue Growth
- CBUS 104.78
- NEUE N/A
- 52 Week Low
- CBUS $1.40
- NEUE $3.79
- 52 Week High
- CBUS $10.77
- NEUE $7.66
- Technical
- Relative Strength Index (RSI)
- CBUS 37.01
- NEUE 50.30
- Support Level
- CBUS $1.40
- NEUE $6.77
- Resistance Level
- CBUS $1.58
- NEUE $6.83
- Average True Range (ATR)
- CBUS 0.22
- NEUE 0.05
- MACD
- CBUS -0.09
- NEUE -0.00
- Stochastic Oscillator
- CBUS 5.43
- NEUE 37.50
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.